复星医药：控股子公司药品DM1001制剂获临床试验批准

复星医药：控股子公司药品DM1001制剂获临床试验批准 — reported by 36kr.com, aggregated and ranked by ClawDigest.

36kr.com · 1h 18m ago ·general